Ernexa Therapeutics Inc. (ERNA): Operating Cash Flow
-$7.02M
Year ended 2025-12-31
-$8.84M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$7.02M | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$15.84M | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$20.41M | n/m | 2025-03-12, From 2023-01-01 |
| 2022-12-31 | -$20.98M | n/m | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | -$23.49M | n/m | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | -$8.10M | n/m | 2022-07-01, From 2020-01-01 |
| 2019-12-31 | $2.74M | +101.0% | 2021-03-11, From 2019-01-01 |
| 2018-12-31 | $1.36M | +148.6% | 2020-03-19, From 2018-01-01 |
| 2017-12-31 | $549.0K | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $23.0K | n/m | 2018-03-09, From 2016-01-01 |
| 2015-12-31 | -$4.18M | n/m | 2017-03-09, From 2015-01-01 |
| 2014-12-31 | -$6.38M | n/m | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $1.74M | -19.2% | 2015-03-27, From 2013-01-01 |
| 2012-12-31 | $2.16M | +275.6% | 2013-03-29, From 2012-01-01 |
| 2011-12-31 | $574.0K | -79.7% | 2013-03-29, From 2011-01-01 |
| 2010-12-31 | $2.83M | n/a | 2012-03-30, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | 2025-12-31 | -$7.02M | n/m |
| CDT Equity Inc. (CDT) | 2025-12-31 | -$15.55M | n/m |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | -$5.41M | n/m |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | -$17.31M | n/m |
| Greenwich LifeSciences, Inc. (GLSI) | 2025-12-31 | -$9.91M | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.47M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$6.85M | n/m |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | -$10.98M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$3.75M | n/m |
Compare ERNA, CDT, JUNS, AEON side by side · Screen every company in Pharmaceutical Preparations ↗